Lumefantrine USP: Complete API Profile

Lumefantrine USP API- API

Lumefantrine USP is an important part of an antimalarial drug that is critical to combatting malaria worldwide. Lumefantrine has proved effective in the treatment outcomes of Malaria, decreasing deaths in malaria endemic countries, as a component of combination therapies. The increase in demand worldwide for potent pharmaceutical active ingredients emphasizes the need for reputable manufacturers with the necessary regulatory and pharmacopeial requirements.

Prism Industries Pvt. Ltd. Is a trusted lumefantrine manufacturer based in India. Their objective is to provide high-purity Lumefantrine USP that adheres to global quality guidelines. Through their high-level of regulatory understanding and advanced facilities they have become a leading lumefantrine API exporter, and an experienced bulk drug manufacturer, that serves global pharmaceutical markets.

What is Lumefantrine USP?

An active pharmaceutical ingredient (API), Lumefantrine USP, forms the key ingredient within fixed dose combinations, which are utilized in the management of uncomplicated Malaria. Lumefantrine USP is considered compliant with quality regulations when the relevant pharmacopeial monograph specifies values that the compound is required to meet with respect to purity, potency and safety.

A fluorene derivative Lumefantrine is a potent antimalarial that targets and damages, and kills the malaria parasite by inhibiting its heme detoxification. Because Lumefantrine has a long half-life it increases efficacy in combination therapies thus, reduces risk of resistance or relapse of malaria.

When producing USP grade Lumefantrine specific parameter values are important and must comply with such parameters like:

Assay (confirmation of content)

Related substances (impurities)

Loss on drying

Residual solvents

Particle size distribution

Heavy metal content limits

These parameters ensure that the Lumefantrine raw material is fit for incorporation into a finished drug product.

Application in the Pharmaceutical Industry

Lumefantrine USP is an essential active ingredient in antimalarial drugs in terms of its use in combination therapies at fixed doses. Often found combined with artemisinin, Lumefantrine is typically administered orally as tablets which is an effective antimalarial treatment regimen with lower rates of resistance.

For both domestic and international sales, it is a key pharmaceutical active ingredient for many antimalarial manufacturers. The supply of the right Lumefantrine raw material can mean the difference for pharmaceutical companies that require quality product, consistent therapeutic outcomes, and smooth regulatory approval processes.

The Lumefantrine raw material can be used for:

The manufacturing of antimalarial combination tablets

The supply of to non-governmental organizations and government agencies

Public health programs targeting countries endemic to Malaria

Generic drug manufacturing

Because the majority of people contracting malaria live in Africa, Asia and Latin America, demand for Lumefantrine USP is only going to continue growing in these areas.

Manufacturing process and quality assurance

Complex chemical synthesis and stringent controls are involved in the manufacture of Lumefantrine USP. To ensure their product is safe and of a consistently high standard the producers of Lumefantrine raw material comply with international standards by following GMP.

Steps involved in manufacturing:

The process of chemical synthesis under precise conditions

Crystallisation and purification

Drying and grinding the compound to obtain the correct particle size

Quality testing

Each batch of Lumefantrine raw material is carefully assessed to check if it matches USP criteria, and Quality control laboratories undertake a wide array of tests to verify the content, purity, and levels of any impurities within the product; methods such as High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Infrared Spectroscopy (IR) and UV-Visible Spectrophotometry are used to confirm specifications. Procedures for maintaining quality through strong batch tracing and product stability studies are essential.

Regulatory compliance and global standards

Currently in the pharmaceutical sector regulations are essential. Lumefantrine USP requires to meet a variety of pharmacopeial and regulatory standards globally. To allow smooth and rapid approval processes, Prism Industries Pvt. Ltd. Ensure its pharmaceutical active ingredients comply with a variety of global guidelines. The key areas in compliance are:

Compliance with USP monograph standards

Adherence to GMP certified manufacturing sites

Strict adherence to documentation processes

Proof of product stability

All export documentation

As a registered lumefantrine API exporter, a Certificate of Analysis (CoA), a Material Safety Data Sheet (MSDS), and all regulatory files required by import countries, is provided for Lumefantrine raw material to its consumers.

Prism Industries Pvt. Ltd.: Reliable Lumefantrine Manufacturer in India

Prism Industries Pvt. Ltd. Is a well established, reliable manufacturer of lumefantrine in India; providing superior pharmaceutical active ingredients to customers worldwide. Their large stock of various pharmaceutical active ingredients and advanced manufacturing facilities enable them to operate in an efficient, compliant manner, with scale and speed when necessary.

Their benefits:

The use of modern manufacturing sites and equipment

Dedicated technical and quality control departments

Effective management of the supply chain

The option of customizable packaging

Reliable deliveries

Prism Industries Pvt. Ltd. Recognize the need for bulk drug manufacturers to be able to supply lumefantrine raw material consistently to antimalarial programs globally.

Export capabilities and global reach

With their expertise as an Indian lumefantrine API exporter, Prism Industries Pvt. Ltd. Is capable of meeting the needs of various international markets, by focusing on producing high-quality Lumefantrine raw material that meets stringent regulatory standards. They have supplied products to manufacturers in various parts of the world; Asia, the Middle East and Africa included.

Additional services available through their export channels include:

Secure, compliance-ready packaging

Controlled environment transportation

Comprehensive export documentation and paperwork

Flexible order sizes

Customer and regulatory support

As a result of their world outlook and capacity as a Lumefantrine manufacturer in India they are the ideal partner for businesses requiring API in bulk.

 

Market demand and future outlook

Due to the continuing large-scale problem of Malaria across the globe, the demand for quality pharmaceutical ingredients for its treatment remains strong. With Lumefantrine as a component in important modern treatments, demand is predicted to continue growing. As more countries look to gain an affordable and accessible medication through generic production, high-quality, compliant, bulk drug manufacturers become ever more crucial for these ventures. The growth expected for the Lumefantrine USP market is due to:

Ongoing global efforts to combat Malaria

Increasing markets for generic medicines

Growing demands from developing economies

The increase in the demand for certified APIs

Conclusion

The essential role of Lumefantrine USP as an antimalarial component in effective, combination therapy-based treatments has made it integral to modern Malaria treatment strategies. The quality of Lumefantrine raw material, in particular, is vital for the production of safe and efficacious medicinal products. Prism Industries Pvt. Ltd. Is a leading manufacturer and supplier of pharmaceutical active ingredients including Lumefantrine USP in India. With their strong global reach, and capacity to produce consistently, their regulatory compliance, and modern manufacturing facility make them a key partner for pharmaceutical businesses seeking a dependable, quality-driven supply chain for Lumefantrine USP.

To discover the full scope of Prism Industries Pvt. Ltd. Their business model, ask for technical information, or arrange a collaboration you may contact their experienced team of bulk drug manufacturers for their Lumefantrine USP supply.

At Prism Industries Pvt. Ltd., we are proud to support such efforts by providing trusted, compliant APIs to innovators in the global pharmaceutical space.

To explore quinine for advanced therapeutic research, contact us today at www.prisminltd.com.

Contact us at www.prisminltd.com/contact to learn more or request a product sample.

Explore Our Products: https://prisminltd.com/products/

Follow us on:

Facebook: https://www.facebook.com/profile.php?id=61559713707912&is_tour_dismissed

Twitter: https://x.com/prismindltd

Linkedin: https://www.linkedin.com/in/prism-industries-589771309/

Instagram : https://www.instagram.com/prism2241

FAQs:

 Lumefantrine USP is a pharmaceutical active ingredient used in combination antimalarial medicines. It meets United States Pharmacopeia (USP) standards for purity, potency, and safety, making it suitable for use in high-quality malaria treatment formulations.

 Lumefantrine works by interfering with the malaria parasite’s ability to detoxify heme inside infected red blood cells. This disruption leads to the accumulation of toxic substances that kill the parasite, helping clear the infection effectively.

Lumefantrine is usually combined with artemisinin derivatives in fixed-dose therapies. This combination improves treatment effectiveness, reduces the risk of drug resistance, and enhances the overall success rate of malaria treatment.

Key quality parameters include assay content, related substances (impurities), loss on drying, residual solvents, heavy metal limits, and particle size distribution. These specifications ensure the API meets pharmacopeial standards and is safe for pharmaceutical formulations.

Lumefantrine raw material is primarily used in the manufacturing of antimalarial combination tablets. It is also supplied for government malaria control programs, public health initiatives, and generic pharmaceutical drug production.

 Lumefantrine API must be produced in GMP-compliant facilities using controlled synthesis, purification, and quality testing processes. Analytical techniques such as HPLC, GC, IR spectroscopy, and UV-Visible testing are commonly used to confirm quality and purity.

 A trusted Lumefantrine manufacturer ensures consistent quality, regulatory compliance, and reliable supply of pharmaceutical active ingredients. This is critical for pharmaceutical companies producing antimalarial medicines for global health programs.